Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Arev Life Sciences Global Corp (OP: AREVF )

0.1050 +0.0950 (+950.00%)
Streaming Delayed Price Updated: 2:57 PM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,000
Open 0.1050
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0100
Today's Range 0.1050 - 0.1050
52wk Range 0.0002 - 0.1187
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Study Reveals Proteins That Can Trigger Immune System Malfunction
Via Investor Brand Network
New Study Finds Some Viruses Can Make You Tastier to Mosquitoes
Via Investor Brand Network

Performance

YTD
+10400.00%
+10400.00%
1 Month
+950.00%
+950.00%
3 Month
+6900.00%
+6900.00%
6 Month
+52400.00%
+52400.00%
1 Year
-11.54%
-11.54%

More News

Read More
New Research Says Immune Cell Proliferation May Be Associated with Multiple Sclerosis Onset
Via Investor Brand Network
Diseases Suppressed by COVID-19 Restrictions Reemerge in Peculiar Ways
Via Investor Brand Network
Exposures COVID-19
Experts Urge Cancer Patients Not to Ignore Any Weight, Muscle Loss While on Treatment
Via Investor Brand Network
Study Links Hypertension During Pregnancy to Future Cardiac Events
Via Investor Brand Network
UNICEF Sounds the Alarm on the Worldwide Child Malnutrition Risk
Via Investor Brand Network
BioMedNewsBreaks — AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) to Conduct Key Research with TransBIOTech, Names New COO
Via Investor Brand Network
BioMedNewsBreaks – AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) Announces Collaboration Agreement with RCFFN, University of Manitoba
Via Investor Brand Network
Exposures COVID-19
AREV Life Sciences enters Into Collaboration Agreement with Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba
Via TheNewswire.com
BioMedNewsBreaks – Why AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) Is ‘One to Watch’
Via Investor Brand Network
BioMedNewsBreaks – AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) Achieves New Milestone, Opens Additional Revenue Stream
Via Investor Brand Network
AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) Is ‘One to Watch’
Via Investor Brand Network
BioMedNewsBreaks – AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) Expands Corporate Efforts as It Advances Closer to Market with Milestone Products
Via Investor Brand Network
AREV Changes their name to AREV Life Sciences Global Corp.
Via TheNewswire.com
AREV Signs Definitive Collaborative Development Agreement with Voynich Biosciences and Invites Richard van Breemen PhD to SAB
Via TheNewswire.com
Data Presented at the 11th IAS Conference on HIV Science Supports AREV's Development of SUS-TAINN(TM), a Ready-to-Use Therapeutic Food to Treat Global Malnutrition and Starvation
Via TheNewswire.com
Topics Climate Change Death
Exposures COVID-19 Climate Death
AREV Annual and Special General Meeting Results Appoints Mel Maxwell as an AREV Director
Via TheNewswire.com
AREV Completes Land Survey and Soil Analysis for Cultivation of Mushrooms and Moringa and Prepares for Mass Production of Plant-Based Proteins for Use in Its Ready-To-Use Therapeutic Foods
Via TheNewswire.com
Exposures COVID-19
AREV CEO Michael Withrow Buys 900,000 Shares of Company Stock
Via TheNewswire.com
Germinator and AREV Nanotech Brands Inc. Sign Distribution Agreement to Provide the Genesis Platform of Surface Disinfection to Global Public Health Commodity Procurement Programs
Via TheNewswire.com
Topics Economy
Exposures COVID-19 Economy
AREV Engages Dr. Harold C. Smith to Join Scientific Advisory Board
Via TheNewswire.com
AREV Nanotec Brands Inc. Announces Management Cease Trade Order Revoked
Via TheNewswire.com
AREV Life Sciences Expands its Extraction Results to Clinical Characterization of Compounds, Development of Advanced-Stage Therapeutic Foods and Discovery of Plant-Based Drugs
Via TheNewswire.com
AREV Nanotec Brands Inc. Provides Management Cease Trade Order Update
Via TheNewswire.com
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.